I Tried This and It Changed Everything
3 extracted signals · 3 resolved · 0 still active
Kenan GraceIndependent analyst profile- Source published
- 31 May 2026, 18:43 UTC
- Recorded by Tahlil Plus
- 31 May 2026, 19:44 UTC
AI-generated source summary
The analysis focuses on two key stocks: IBM and UMAC. For IBM, the current price is $298.10, with an intraday gain of 12.79%. The year-to-date performance shows a loss of 0.18%, indicating a recovery from a significant drop to around $200. The target for IBM is identified around $350, with a critical support level at $273.35, and potential for further upside if it breaks above $310. For UMAC (Unusual Machines, Inc.), the current price is $31.11, up 7.57% today. The analysis highlights two key price levels for UMAC: a support at $10-$12 and a breakout resistance at $31-$32, with a target of $40. The negative P/E ratio of -95.24 for UMAC suggests it is not currently profitable, but the focus is on its potential for growth in the drone technology sector, particularly in first-person view (FPV) systems and AI infrastructure. The overall market sentiment suggests a bullish outlook for these technology stocks, driven by investment in AI and technological advancements.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Kenan Grace
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.